Sized right for every challenge.
You don’t have to be a big company to be treated like one: If you’re part of a small or mid-sized biotech, you’ll welcome our hands-on support with the kind of capacity that can grow as your needs do.
What's new at resilience
Upcoming Events
Manufacturing SOLUTIONS Custom-Fit to Your Needs
We were founded with a straightforward yet bold purpose: to broaden access to complex medicines and to protect biopharmaceutical supply chains against disruption. At the heart of our approach is a network of high-tech, end-to-end drug substance and drug product manufacturing solutions that can help ensure the medicines of today and tomorrow can be made quickly, safely, and at scale.
Biologics
Conventional and evolved platforms engineered to help you capitalize on the potential of your recombinant protein and monoclonal antibody (mAb) discoveries
Vaccines
Live viruses, viral vectors and other components (including infectivity and potency assays) to enable more efficient, effective vaccine development
Gene Therapy
Process and analytical development for viral vector productions and next-generation testing methods to take your innovation from starting material to product release
Cell Therapy
Modular manufacturing processes designed to leverage the most promising emerging technologies for blood and bone marrow-centered therapies
Nucleic Acids
A powerful mRNA platform, integrated supply chain and solid-state chemistry capabilities to provide a more direct, holistic path forward from first concept
THE BENEFITS OF WORKING WITH RESILIENCE
When you engage with Resilience as your CDMO biomanufacturing partner, you get the kind of thinking – backed by the kind of resources necessary – to future-proof the next stages of your discovery.
We do that by delivering three crucial advantages to your team:
Aligned incentives to accelerate development and to provide the investment, know-how and experience you need to optimize opportunities
Access to best-in-class development platforms derived from breakthroughs across five key modalities
A digital-first enterprise committed to delivering on the promise of cloud-based systems, advanced AI, and next-level visibility and data security
.webp)
